Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Ketorolac Tromethamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 2 Carcinoma, Renal Cell 2 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Kidney Neoplasms 1 Ileus 1 Fallopian Tube Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Curative Breast Cancer Surgery 1 Constipation 1 Colonic Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1 Agnosia 1 Acute Pain 1

Interventions

Tamoxifen 4 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03007381 2017-08-16

KANGAROO

Nova Scotia Health Authority

Phase 4 Withdrawn

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡